Foundation For Innovative New Diagnostics (Find)
Le Grand-Saconnex, GE
- UEI
- TF1DH8S7GVG3
- CAGE
- SEV36
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- SAM.gov registration date
- Physical address
- Chem. du Pommier 40, 1218 Le Grand-Saconnex, Switzerland
- Website
- finddx.org
- Founded
- 2003
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Financials
- Diversified Financials
- Capital Markets
- Fundraising
- SIC code
- 83 Social Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| PS10-10121, HQ (pepfar): building global capacity for diagnostic testing of tuberculosis, malaria and HIV | Office of Financial Resources | -$1,310,007 | |
| Building global capacity for diagnostic testing of tuberculosis, malaria and HIV | Centers for Disease Control and Prevention | $15,006,101 |
About Foundation For Innovative New Diagnostics (Find)
Foundation For Innovative New Diagnostics (Find) is a foreign owned, non-profit organization and foundation registered in SAM.gov since 2008. Find provides various goods and services related to disease diagnostics to the federal government through contracts and grants.
Find has not received any prime federal contracts, but has received one federal sub-contract from the Trustees of Boston University to support product developers funded through CARB-X, an antibacterial resistance initiative. Specifically, Find provided guidance, monitoring, educational materials, and community development support to help these product developers advance new diagnostics and treatments.
Through federal grants, Find has provided numerous goods and services related to tuberculosis (TB) diagnostics, often as a sub-awardee. These include strengthening TB diagnosis through improving pediatric sample collection and testing in India; supporting the FEND-TB and R2D2 TB research consortia focused on TB diagnostics; providing biorepository services; and evaluating new computer aided detection software for TB using chest X-rays. Find also provided technical assistance to implement diagnostic strengthening activities related to the RISE TB control project across multiple states in India. Additionally, Find partnered with Rutgers University and Jhpiego Corporation on federal grants to advance TB control efforts globally.
Quick answers
What is Foundation For Innovative New Diagnostics (Find)'s UEI?
Foundation For Innovative New Diagnostics (Find)'s Unique Entity ID (UEI) in SAM.gov is TF1DH8S7GVG3.
What is Foundation For Innovative New Diagnostics (Find)'s CAGE code?
Foundation For Innovative New Diagnostics (Find)'s CAGE code is SEV36.
Where is Foundation For Innovative New Diagnostics (Find) located?
Foundation For Innovative New Diagnostics (Find)'s physical address in SAM.gov is Chem. du Pommier 40, 1218 Le Grand-Saconnex, Switzerland.
Is Foundation For Innovative New Diagnostics (Find) registered in SAM.gov?
Yes. Foundation For Innovative New Diagnostics (Find)'s SAM.gov registration is active through September 2, 2027.
What is Foundation For Innovative New Diagnostics (Find)'s most recent federal award?
Foundation For Innovative New Diagnostics (Find)'s most recent federal grant award is PS10-10121, HQ (pepfar): building global capacity for diagnostic testing of tuberculosis, malaria and HIV (NU2GPS002746), from Office of Financial Resources, on September 30, 2010.
On GovTribe
See Foundation For Innovative New Diagnostics (Find)'s full federal record
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors